Events
Celesq® CLE Program: FDA in the Year of COVID – How FDA Tackled the Pandemic and What to Expect from FDA in 2021
February 11, 2021

On February 11, Axinn partner Chad Landmon and associate Alex Alfano presented a Celesq® CLE program entitled, "FDA in the Year of COVID – How FDA Tackled the Pandemic and What to Expect from FDA in 2021." This program looked forward to 2021, and discussed whether FDA’s operations will go back to their pre-pandemic normal and how FDA might continue to use real world evidence to support important regulatory decisions.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.